Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 497 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)

NCT02307149

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • City of Hope National Medical Center, Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic & Research Institute Los Angeles, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View Trial Details
Completed

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

NCT02731729

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)

NCT02434107

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Humboldt-Universität Berlin Charité Berlin, Germany
  • Krankenhaus Neukölln Berlin, Germany
  • Universtitäts-Hautklinik Bochum Bochum, Germany
  • Zentralkrankenhaus Bremen, Germany
View all 41 locations
View Trial Details

Related conditions